Breaking News Instant updates and real-time market news.

AVYA

Avaya

$11.51

0.1 (0.88%)

15:05
07/05/19
07/05
15:05
07/05/19
15:05

Avaya Holdings call volume above normal and directionally bullish

Bullish option flow detected in Avaya Holdings with 2,571 calls trading, 2.0x expected, and implied vol increasing over 1 point to 62.62%. Jul-19 12.5 calls and Dec-19 10 puts are the most active options, with total volume in those strikes near 3,000 contracts. The Put/Call Ratio is 0.20. Earnings are expected on August 8th.

AVYA Avaya
$11.51

0.1 (0.88%)

05/10/19
BWSF
05/10/19
NO CHANGE
Target $22
BWSF
Buy
Avaya price target lowered to $22 from $32 at BWS Financial
BWS Financial analyst Hamed Khorsand lowered his price target for Avaya to $22 from $32 saying the company has an "up-hill challenge of regaining investor confidence" following the weaker than expected fiscal Q2 results. Avaya claimed Reuters' story of the company being approached by a third party caused some customers to hold off on hardware and software licenses at the very end of the quarter. Khorsand, however, said he has "never seen this kind of excuse used before and find it difficult to believe." Nonetheless, given the stock's discount to his new price target, the analyst keeps a Buy rating on Avaya.
04/09/19
BWSF
04/09/19
NO CHANGE
Target $32
BWSF
Buy
Avaya could fetch up to $25 from PE buyer, says BWS Financial
Additional news reports about Avaya (AVYA) possibly going private since an initial Reuters report build some credibility about the news, said BWS Financial analyst Hamed Khorsand, who believes Avaya could fetch as much as $25 from a private equity buyer using fiscal 2019 estimates and could be worth as much $30 assuming no improvement in the business for fiscal 2020. He thinks greater synergies could be extracted by a strategic buyer and continues to believe Microsoft (MSFT) would be the best fit as an acquirer. Khorsand keeps a Buy rating and $32 price target on Avaya shares.
03/27/19
BWSF
03/27/19
NO CHANGE
Target $32
BWSF
Strong Buy
Avaya back on investor radars after buyout report, says BWS Financial
A report from Reuters about Avaya (AVYA) possibly being acquired by private equity has put the stock back on investors' radars, BWS Financial analyst Hamed Khorsand tells investors in a research note. He believes the "misunderstanding" of the company's business had "created a significant value gap." The analyst notes, however, that the news report suggests a takeover bid of $20, which is well below his price target of $32. The delta between the reported takeout price and the $32 target is predominately set on how much debt private equity would be willing to put back on Avaya's balance sheet, Khorsand contends. The analyst continues to believe there is "considerable possibility" of Avaya purchasing technology to fill-in its cloud offering. However, that should not prevent a going private bid, says Khorsand. He has a Buy rating on Avaya.
03/11/19
GUGG
03/11/19
INITIATION
Target $22
GUGG
Buy
Avaya initiated with a Buy at Guggenheim
Guggenheim analyst Nandan Amladi started Avaya with a Buy rating and $22 price target. As a newly public company post-bankruptcy, Avaya has emerged with a "much stronger focus" on recurring revenue and an "aggressive" cloud roadmap targeting 25% of total revenue by fiscal 2021, from about 12% today, Amladi tells investors in a research note. He cites the company's combination of a "credible strategic pivot" and an "attractive valuation" for his Buy rating.

TODAY'S FREE FLY STORIES

UAL

United Continental

$94.00

2.7 (2.96%)

16:18
07/16/19
07/16
16:18
07/16/19
16:18
Earnings
United Continental reports Q2 adjusted EPS $4.21, consensus $4.08 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

VNDA

Vanda Pharmaceuticals

$13.45

-0.13 (-0.96%)

16:18
07/16/19
07/16
16:18
07/16/19
16:18
Hot Stocks
Vanda Pharmaceuticals announces study results for tradipitant »

Vanda Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

STIM

Neuronetics

$12.65

-0.2 (-1.56%)

, UNH

UnitedHealth

$264.60

-1.31 (-0.49%)

16:18
07/16/19
07/16
16:18
07/16/19
16:18
Recommendations
Neuronetics, UnitedHealth analyst commentary  »

UnitedHealth coverage…

STIM

Neuronetics

$12.65

-0.2 (-1.56%)

UNH

UnitedHealth

$264.60

-1.31 (-0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

CTAS

Cintas

$239.46

-3.85 (-1.58%)

16:17
07/16/19
07/16
16:17
07/16/19
16:17
Earnings
Cintas sees FY20 EPS $8.30-$8.45, consensus $8.32 »

Sees FY20 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

UAL

United Continental

$94.00

2.7 (2.96%)

16:17
07/16/19
07/16
16:17
07/16/19
16:17
Earnings
United Continental raises FY19 adj. EPS view to $10.50-$12.00, consensus $11.33 »

Prior view was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
07/16/19
07/16
16:17
07/16/19
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTAS

Cintas

$239.46

-3.85 (-1.58%)

16:16
07/16/19
07/16
16:16
07/16/19
16:16
Earnings
Cintas reports Q4 EPS ex-items $2.07, consensus $1.93 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

CSX

CSX

$79.57

1.05 (1.34%)

16:16
07/16/19
07/16
16:16
07/16/19
16:16
Hot Stocks
CSX says merchandise growth 'offset' intermodal weakness »

Chemicals increased as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 26

    Aug

  • 13

    Nov

PETX

Aratana Therapeutics

$4.94

-0.11 (-2.18%)

16:16
07/16/19
07/16
16:16
07/16/19
16:16
Hot Stocks
Aratana Therapeutics shareholders vote to adopt merger with Elanco Animal Health »

Aratana Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
07/16/19
07/16
16:16
07/16/19
16:16
Technical Analysis
NYSE market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Continental

$94.00

2.7 (2.96%)

16:15
07/16/19
07/16
16:15
07/16/19
16:15
Earnings
United Continental reports Q2 adjusted EPS $4.21, consensus $4.08 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

KSFTF

Kingsoft

$0.00

(0.00%)

16:15
07/16/19
07/16
16:15
07/16/19
16:15
Downgrade
Kingsoft rating change  »

Kingsoft downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSX

CSX

$79.68

1.16 (1.48%)

16:13
07/16/19
07/16
16:13
07/16/19
16:13
Hot Stocks
CSX reports Q2 operating ratio fell to 57.4% since Q2 last year »

Last year's Q2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 26

    Aug

  • 13

    Nov

PDD

Pinduoduo

$20.13

0.77 (3.98%)

16:12
07/16/19
07/16
16:12
07/16/19
16:12
Downgrade
Pinduoduo rating change  »

Pinduoduo downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NCBS

Nicolet Bankshares

$62.76

0.13 (0.21%)

16:12
07/16/19
07/16
16:12
07/16/19
16:12
Earnings
Nicolet Bankshares reports Q1 EPS $1.91 with items, consensus $1.09 »

During Q2, Nicolet sold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WB

Weibo

$41.65

-1.39 (-3.23%)

16:12
07/16/19
07/16
16:12
07/16/19
16:12
Downgrade
Weibo rating change  »

Weibo downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTRP

Ctrip

$36.88

-0.47 (-1.26%)

16:12
07/16/19
07/16
16:12
07/16/19
16:12
Upgrade
Ctrip rating change  »

Ctrip upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSX

CSX

$79.67

1.15 (1.46%)

16:11
07/16/19
07/16
16:11
07/16/19
16:11
Hot Stocks
CSX falls 6% after reporting Q2 results below expectations »

CSX shares are trading at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 26

    Aug

  • 13

    Nov

SENS

Senseonics

$1.68

-0.075 (-4.29%)

16:10
07/16/19
07/16
16:10
07/16/19
16:10
Syndicate
Senseonics announces $80M convertible senior notes offering »

Senseonics Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

GALXF

Galaxy Resources

$0.00

(0.00%)

16:10
07/16/19
07/16
16:10
07/16/19
16:10
Downgrade
Galaxy Resources rating change  »

Galaxy Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INO

Inovio

$2.99

0.04 (1.36%)

16:09
07/16/19
07/16
16:09
07/16/19
16:09
Hot Stocks
Inovio to reduce annual burn rate by 25% and workforce by 28% »

Inovio Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SENS

Senseonics

$1.68

-0.075 (-4.29%)

16:08
07/16/19
07/16
16:08
07/16/19
16:08
Syndicate
Senseonics announces $25M common stock offering »

Senseonics Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

BYSI

BeyondSpring

$19.16

-0.12 (-0.62%)

16:08
07/16/19
07/16
16:08
07/16/19
16:08
Syndicate
BeyondSpring files to sell common stock, no amount given »

William Blair &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRSK

Verisk Analytics

$151.78

-0.48 (-0.32%)

16:07
07/16/19
07/16
16:07
07/16/19
16:07
Hot Stocks
Appriss acquires retail loss prevention solutions from Verisk Analytics »

Appriss announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 12

    Aug

  • 06

    Sep

FTSV

Forty Seven

$10.08

-0.07 (-0.69%)

16:07
07/16/19
07/16
16:07
07/16/19
16:07
Syndicate
Forty Seven announces $75M common stock offering »

Forty Seven announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.